NCT02437084View on ClinicalTrials.gov

Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling

PHASE4CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 29, 2020

Study Completion Date

April 30, 2020

Conditions
HyperlipidemiaInsulin ResistanceType 2 Diabetes
Interventions
DRUG

Atorvastatin

Study subjects will receive atorvastatin 40 mg for 10 weeks.

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

Doris Duke Charitable Foundation

OTHER

lead

Stanford University

OTHER

NCT02437084 - Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling | Biotech Hunter | Biotech Hunter